Kanna Health Ltd

Overview

Legal name

KANNA HEALTH LTD

Region

South East England

Registered address

1ST FLOOR

ONE SUFFOLK WAY

SEVENOAKS

KENT

ENGLAND

TN13 1YL

Insolvency history

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller

Company Active LTD

Kanna Health Ltd

CRN 13333949

Direct and ultimate controller Active LTD

Pangea Botanica Ltd

CRN 13246726

Company events

Reference milestones and recent Companies House filing stream events.

7 events

31 Mar

2027

Accounts due

Accounts Due

Next accounts due date

28 Dec

2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

14 Dec

2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Jun

2025

Accounts filed

Accounts

Last accounts made up date

27 Sep

2024

Accounts With Accounts Type Total Exemption Full

Accounts Awaiting analysis

AA | Transaction MzQzNzUzMDcxOGFkaXF6a2N4

Published 27 Sep 2024 12:59

16 Aug

2024

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzQzMjUyMTMzNGFkaXF6a2N4

Published 16 Aug 2024 16:56

14 Apr

2021

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2025

Funded years

2025

Age at first award

4 years

Projects

2025 Collaborative R&D Lead participant

A novel treatment for anxiety disorders that is fast-acting and well tolerated with low abuse liability compared to current treatments

1 Nov 2025 to 30 Apr 2027

Awarded

£492,721

Total cost £703,887

Kadence Bio (Kadence) is a UK-based biotech SME. Mental health issues are the leading cause of disability in the UK, accounting for up to 22.8% of the total associated economic burden. In 2022, approximately one in six UK adults reported experiencing a common mental health problem during any given week, with anxiety levels in the UK reaching their highest...

Product types

Collaborative R&D